Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective

por Régnier, Stephane A, Malcolm, William, Haig, Jennifer, Xue, Weiguang
Publicado 2015

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccin...

por Kohli, Michele, Lawrence, Donna, Haig, Jennifer, Anonychuk, Andrea, Demarteau, Nadia
Publicado 2012

Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK

por Claxton, Lindsay, Malcolm, Bill, Taylor, Matthew, Haig, Jennifer, Leteneux, Claudia
Publicado 2014